Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing Access Your Profit Alerts

How We Grabbed 55% in Just 20 Days

Shares of Anika Therapeutics Inc. (NYSE: ANIK) zoomed as much as 52% yesterday after the U.S. Food and Drug Administration (FDA) approved the bioscience firm's arthritis treatment.

The stock closed 33% higher, giving us a 55% gain on Anika just 20 days.

And this hefty run-up is merely the start.

Leave a Reply

Your email address will not be published. Required fields are marked *

Some HTML is OK